Ian Charles
Direktor/Vorstandsmitglied bei Norwich Research Partners LLP
Profil
Ian Charles was the founder of Auspherix Ltd.
(2013) and Longas Technologies Pty Ltd.
(2015), where he held the titles of Director & Chief Scientific Officer and Director, respectively.
Dr. Charles is also the founder of Arrow Therapeutics Ltd.
Currently, Dr. Charles is a Director at Norwich Research Partners LLP.
Previously, he held the position of Independent Non-Executive Director at Genus Plc from 2018 to 2021.
Dr. Charles also held Director positions at the University of Technology Sydney, Quadram Institute Bioscience, Ithree Institute, and was a founding member of Wolfson Institute For Biomedical Research.
Dr. Charles earned a doctorate degree from the University of Leicester.
Aktive Positionen von Ian Charles
| Unternehmen | Position | Beginn |
|---|---|---|
Norwich Research Partners LLP
 Norwich Research Partners LLP Miscellaneous Commercial ServicesCommercial Services Norwich Research Partners LLP operates as a business community. The private company is based in Norwich, UK. The British company was founded in 2012. The CEO is David Parfrey. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Ian Charles
| Unternehmen | Position | Ende |
|---|---|---|
| GENUS PLC | Direktor/Vorstandsmitglied | 31.05.2021 |
Auspherix Ltd.
 Auspherix Ltd. BiotechnologyHealth Technology Auspherix Ltd. operates as an early stage anti-infectives company which develops novel antibiotics to treat resistant bacterial diseases. The firm uses a library screening approach to identify drugs with novel mechanisms of action as antibiotics. The company was founded by Ian Charles and Dagmar Alber in 2013 and is headquartered in Stevenage, the United Kingdom. | Gründer | 30.04.2019 |
| Wolfson Institute For Biomedical Research | Corporate Officer/Principal | - |
| Ithree Institute | Direktor/Vorstandsmitglied | - |
Longas Technologies Pty Ltd.
 Longas Technologies Pty Ltd. Miscellaneous Commercial ServicesCommercial Services Longas Technologies Pty Ltd. is engaged in developing next generation sequencing (NGS) technologies. The company was founded by Ian Charles, Aaron Darling, and Catherine Burke in 2015 and is headquartered in Sydney, Australia. | Gründer | - |
Ausbildung von Ian Charles
| University of Leicester | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| GENUS PLC | Process Industries |
| Private Unternehmen | 6 |
|---|---|
Arrow Therapeutics Ltd.
 Arrow Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Arrow Therapeutics Ltd. operates as a pharmaceutical company that focuses on research and development of novel antiviral drugs. Its products include novel antibacterial, antiviral, antifungal and preclinical compounds. The company was founded in 1998 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
Quadram Institute Bioscience
 Quadram Institute Bioscience Miscellaneous Commercial ServicesCommercial Services Quadram Institute Bioscience operates as a non-profit organization that provides food research for health and prevention of food related diseases. The organization serves science research base, industry, clinical practice via health and preventive medicine and evidence-based policy for government and industry. The company was founded in November 1986 and is headquartered in Norwich, the United Kingdom. | Commercial Services |
Norwich Research Partners LLP
Norwich Research Partners LLP Miscellaneous Commercial ServicesCommercial Services Norwich Research Partners LLP operates as a business community. The private company is based in Norwich, UK. The British company was founded in 2012. The CEO is David Parfrey. | Commercial Services |
Longas Technologies Pty Ltd.
Longas Technologies Pty Ltd. Miscellaneous Commercial ServicesCommercial Services Longas Technologies Pty Ltd. is engaged in developing next generation sequencing (NGS) technologies. The company was founded by Ian Charles, Aaron Darling, and Catherine Burke in 2015 and is headquartered in Sydney, Australia. | Commercial Services |
| Wolfson Institute For Biomedical Research | |
Auspherix Ltd.
Auspherix Ltd. BiotechnologyHealth Technology Auspherix Ltd. operates as an early stage anti-infectives company which develops novel antibiotics to treat resistant bacterial diseases. The firm uses a library screening approach to identify drugs with novel mechanisms of action as antibiotics. The company was founded by Ian Charles and Dagmar Alber in 2013 and is headquartered in Stevenage, the United Kingdom. | Health Technology |
